Our previously mentioned results come in matching with the findings reported by other researchers, who reported that serum level of MPO was significantly elevated after DOX administration and MPO level was linked to cardiotoxicity in patients with breast cancer who received DOX (Ky et al. 2014). The gene discussed is MPO; the disease is breast carcinoma.